ApprovalTrail

Approval · Notice of Compliance 4023 · 1997

PINDOLOL: Notice of Compliance 4023

Issued March 6, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4023
Date
March 6, 1997
Company
Prempharm Inc.Etobicoke, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Antihypertensive, antianginal agent

Products in this notice

BrandDINStatus today
PINDOLOL02230739—
PINDOLOL02230740—
PINDOLOL02230741—

Medicinal ingredients